9 records totalling $5,525,571.00 CAD, from official Government of Canada open data.
| Canadian Institutes of Health Research | $5,525,571 | 9 records |
Aldosterone antagonism and enhanced Clearance for Health Improvement EValuation in End-stage renal disease (ACHIEVE) Trial
The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...
The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis: extended follow-up of a randomized controlled trial
Improving patient important outcomes for hemodialysis patients using pharmacological and dialysis-based strategies
Remote Ischemic Preconditioning in Cardiac Surgery Trial (Remote IMPACT)
Protection of the heart with aldosterone antagonism in end-stage renal disease (PHASE 2) Trial
Protection of the heart with aldosterone antagonism in end-stage renal disease (PHASE 2) Trial
Pilot trial of Hemodialysis patients undergoing Aldosterone antagoniSm with Eplerenone (PHASE)